Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Teoxane proposal to acquire Revance Therapeutics
We are advising Teoxane on the proposed acquisition
Paychex $4.1 billion acquisition of Paycor HCM
We are advising Paychex on the transaction
Vialto Partners recapitalization
We are advising an ad hoc group of first-lien lenders in connection with the transaction
Boparan £470 million refinancing
We advised on a high-yield notes offering, tender offer and credit facility refinancing
Crane NXT £300 million acquisition of De La Rue’s authentication division
We are advising Crane NXT on the acquisition
Millicom tender offer by Atlas Luxco
We are advising Millicom’s independent committee on the tender offer
Emerson $3.5 billion sale of remaining interests in Copeland to Blackstone
We are advising Emerson on the sale
Nuvei $6.3 billion going-private acquisition
We are advising Nuvei on the transaction
Viavi Solutions $1.2 billion Spirent Communications acquisition financing
We are advising the agent and lead arranger on the financing